Why Genezen?

Why Genezen? We’re a focused company dedicated to exceptional gene and cell therapy. When you’re ready to start or shift your development journey, our team offers the guidance, expertise, technology, and manufacturing capacity to help bring your viral vector therapy to patients with accuracy and speed.

Scroll Down

Complete development capabilities

Accelerate your therapy's development

Making viral vector production accessible, we act with care to realize the immense potential of your products.

Breaking through barriers

Client-centric guidance paired with complete development capabilities and manufacturing capacity, we can provide tailored solutions and help you overcome challenges and accelerate your therapy’s development.

Well-connected and collaborative experts

Leverage our specialist expertise and powerful network of academic and research partners. Founded to connect biotech and academia, we have collaboration in our DNA.

Backed by experience and financial possibilities

Expansive expertise in lentiviral vectors

Lentiviral vectors are an innovative area in cell therapy and are one of the more challenging and complex viral vectors to develop and manufacture. We have unique knowledge and technical talent within our team.

Plan for your future

Our entrepreneurial spirit and experience are backed by the financial investment of Ampersand Capital Partners, securing the resources and action plan to support our clients from concept to commercialization.

Get in touch

Meet our People

Our team is dedicated to getting your viral vector where it needs to go. Communication and collaboration are part of our DNA and we can't wait to talk to you about your current challenges and needs.

Brok Weichbrodt

VP of Operations

Pratima Cherukuri

Chief Scientific Officer

Ray Kaczmarek

Chief Executive Officer